First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis (Q34421386)

2 August 2017

0 references

First-trimester exposure to metformin and risk of birth defects: a systematic review and meta-analysis (English)

1 reference

2 August 2017

0 references

1 reference

1 reference

Matteo Cassina

1

0 references

author name string

Marta Donà

2

1 reference

2 August 2017

Elena Di Gianantonio

3

1 reference

2 August 2017

Pietro Litta

4

1 reference

2 August 2017

Maurizio Clementi

5

1 reference

2 August 2017

25 May 2014

1 reference

Human Reproduction Update

2 August 2017

1 reference

2 August 2017

20

1 reference

2 August 2017

5

1 reference

2 August 2017

656-669

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

2 August 2017

1 reference

Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin improves ovulation and pregnancy rates in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Prevention of gestational diabetes mellitus by continuing metformin therapy throughout pregnancy in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Continuation of metformin in the first trimester of women with polycystic ovarian syndrome is not associated with increased perinatal morbidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Insulin resistance in nonobese patients with polycystic ovarian disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Population pharmacokinetics of metformin in late pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Fasting blood glucose predicts response to extended-release metformin in gestational diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Use of metformin in polycystic ovary syndrome: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Effect of treatment of gestational diabetes mellitus on pregnancy outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin pharmacokinetics in nondiabetic pregnant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Prevalence of insulin resistance in the polycystic ovary syndrome using the homeostasis model assessment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Oral hypoglycemic agents vs insulin in management of gestational diabetes: a systematic review and metaanalysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Polycystic ovarian syndrome: pathophysiology, molecular aspects and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Adverse effects of the common treatments for polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Pharmacokinetics of metformin during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Continuing metformin throughout pregnancy in women with polycystic ovary syndrome appears to safely reduce first-trimester spontaneous abortion: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Pregnancy outcomes among women with polycystic ovary syndrome treated with metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin therapy throughout pregnancy reduces the development of gestational diabetes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin, pre-eclampsia, and pregnancy outcomes in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Height, weight, and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin during pregnancy reduces insulin, insulin resistance, insulin secretion, weight, testosterone and development of gestational diabetes: prospective longitudinal assessment of women with polycystic ovary syndrome from preconception throughou

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Effects of metformin-diet intervention before and throughout pregnancy on obstetric and neonatal outcomes in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin for gestational diabetes in routine clinical practice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Clinical Pharmacokinetics of Metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin vs insulin in the management of gestational diabetes: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Oral hypoglycaemic agents in 118 diabetic pregnancies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Pregnancy in women with Type 2 diabetes: who takes metformin and what is the outcome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin should be considered in the treatment of gestational diabetes: a prospective randomised study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

PCOSMIC: a multi-centre randomized trial in women with PolyCystic Ovary Syndrome evaluating Metformin for Infertility with Clomiphene.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Can metformin reduce the incidence of gestational diabetes mellitus in pregnant women with polycystic ovary syndrome? Prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Determination of metformin transfer across the human placenta using a dually perfused ex vivo placental cotyledon model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Carrier-mediated transport of metformin across the human placenta determined by using the ex vivo perfusion of the placental cotyledon model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Gestational diabetes: the consequences of not treating

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: A systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Status of clomiphene citrate and metformin for infertility in PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin versus clomiphene citrate for infertility in non-obese women with polycystic ovary syndrome: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Effect of clomifene citrate plus metformin and clomifene citrate plus placebo on induction of ovulation in women with newly diagnosed polycystic ovary syndrome: randomised double blind clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

The role of metformin in polycystic ovary syndrome: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Continuation of metformin reduces early pregnancy loss in obese Pakistani women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Does continuous use of metformin throughout pregnancy improve pregnancy outcomes in women with polycystic ovarian syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin administration versus laparoscopic ovarian diathermy in clomiphene citrate-resistant women with polycystic ovary syndrome: a prospective parallel randomized double-blind placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine inseminatio

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Prospective parallel randomized, double-blind, double-dummy controlled clinical trial comparing clomiphene citrate and metformin as the first-line treatment for ovulation induction in nonobese anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin administration and laparoscopic ovarian drilling improve ovarian response to clomiphene citrate (CC) in oligo-anovulatory CC-resistant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Uterine effects of metformin administration in anovulatory women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Efficacy predictors for metformin and clomiphene citrate treatment in anovulatory infertile patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Laparoscopic ovarian diathermy vs clomiphene citrate plus metformin as second-line strategy for infertile anovulatory patients with polycystic ovary syndrome: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin reduces risk of ovarian hyperstimulation syndrome in patients with polycystic ovary syndrome during gonadotropin-stimulated in vitro fertilization cycles: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Does metformin affect the ovarian response to gonadotropins for in vitro fertilization treatment in patients with polycystic ovary syndrome and reduced ovarian reserve? A randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Effects of in-utero exposure to oral hypoglycaemic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin in the treatment of clomiphene citrate-resistant women with high BMI and primary infertility: clinical results and reproductive outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin in the treatment of clomiphene citrate-resistant women with polycystic ovary syndrome undergoing in vitro fertilisation treatment: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin--a convenient alternative to insulin for Indian women with diabetes in pregnancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

How metformin acts in PCOS pregnant women: insights into insulin secretion and peripheral action at each trimester of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin versus insulin for the treatment of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Pharmacokinetics and pharmacodynamics of metformin in healthy subjects and patients with noninsulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Clinical pharmacokinetics of metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Is metformin indicated as primary ovulation induction agent in women with PCOS? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Randomized trial of metformin vs insulin in the management of gestational diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Effect of metformin on ovulation and reproductive outcomes in women with polycystic ovary syndrome: a meta-analysis of randomized controlled trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin exposure affects human and mouse fetal testicular cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

The role of organic cation transporters (OCTs) in the transfer of metformin in the dually perfused human placenta

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Pregnancy outcome in infertile patients with polycystic ovary syndrome who were treated with metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin kinetics in healthy subjects and in patients with diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Outcome of clinical pregnancies after ovulation induction using metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin increases the ovulatory rate and pregnancy rate from clomiphene citrate in patients with polycystic ovary syndrome who are resistant to clomiphene citrate alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Placental passage of metformin in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin accumulation: lactic acidosis and high plasmatic metformin levels in a retrospective case series of 66 patients on chronic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMU022

21 January 2018

Identifiers

DOI

10.1093/HUMUPD/DMU022

1 reference

2 August 2017

1 reference